Genentech exec, three Caremark execs acquitted in Medicare/Medicaid Protropin kickback trial.
Executive Summary
GENENTECH EXEC, THREE CAREMARK EMPLOYEES ACQUITTED of all charges in the Medicare/Medicaid anti-remuneration trial by Minneapolis federal court Judge David Doty Oct. 3. Genentech VP-Sales & Marketing Edmon Jennings and Caremark VPs James Mieszala and Joseph Herring and General Manager Judy Giel were cleared of the Minnesota U.S. Attorney's August 1994 charges that they had provided kickbacks to physicians in exchange for prescribing Genentech's Protropin human growth hormone ("The Pink Sheet" Aug. 8, 1994, p. 3).